These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 34607940)

  • 41. Cross-protective immunity following coronavirus vaccination and coronavirus infection.
    Dangi T; Palacio N; Sanchez S; Park M; Class J; Visvabharathy L; Ciucci T; Koralnik IJ; Richner JM; Penaloza-MacMaster P
    J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34623973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection.
    Wang Y; Duan F; Zhu Z; Yu M; Jia X; Dai H; Wang P; Qiu X; Lu Y; Huang J
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19.
    Cooper RS; Fraser AR; Smith L; Burgoyne P; Imlach SN; Jarvis LM; Turner DM; Zahra S; Turner ML; Campbell JDM
    Front Immunol; 2020; 11():598402. PubMed ID: 33488592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exposure to lung-migrating helminth protects against murine SARS-CoV-2 infection through macrophage-dependent T cell activation.
    Oyesola OO; Hilligan KL; Namasivayam S; Howard N; Clancy CS; Zhao M; Oland SD; Kiwanuka KN; Garza NL; Lafont BAP; Johnson RF; Mayer-Barber KD; Sher A; Loke P
    Sci Immunol; 2023 Aug; 8(86):eadf8161. PubMed ID: 37566678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection.
    Choi SS; van Unen V; Zhang H; Rustagi A; Alwahabi SA; Santos AJM; Chan JE; Lam B; Solis D; Mah J; Röltgen K; Trope W; Guh-Siesel A; Lin Z; Beck A; Edwards C; Mallajosyula V; Martin BA; Dunn JCY; Shrager J; Baric RA; Pinsky B; Boyd SD; Blish CA; Davis MM; Kuo CJ
    Res Sq; 2023 May; ():. PubMed ID: 37205380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New tool to investigate spike-specific CD4
    Flemming A
    Nat Rev Immunol; 2022 May; 22(5):275. PubMed ID: 35396463
    [No Abstract]   [Full Text] [Related]  

  • 49. Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone.
    Siska PJ; Decking SM; Babl N; Matos C; Bruss C; Singer K; Klitzke J; Schön M; Simeth J; Köstler J; Siegmund H; Ugele I; Paulus M; Dietl A; Kolodova K; Steines L; Freitag K; Peuker A; Schönhammer G; Raithel J; Graf B; Geismann F; Lubnow M; Mack M; Hau P; Bohr C; Burkhardt R; Gessner A; Salzberger B; Wagner R; Hanses F; Hitzenbichler F; Heudobler D; Lüke F; Pukrop T; Herr W; Wolff D; Spang R; Poeck H; Hoffmann P; Jantsch J; Brochhausen C; Lunz D; Rehli M; Kreutz M; Renner K
    J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    Bansal S; Perincheri S; Fleming T; Poulson C; Tiffany B; Bremner RM; Mohanakumar T
    J Immunol; 2021 Nov; 207(10):2405-2410. PubMed ID: 34654691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    Tenforde MW; Self WH; Adams K; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Olson SM; Kobayashi M; Verani JR; Patel MM;
    JAMA; 2021 Nov; 326(20):2043-2054. PubMed ID: 34734975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T cell immunity to SARS-CoV-2.
    Niessl J; Sekine T; Buggert M
    Semin Immunol; 2021 Jun; 55():101505. PubMed ID: 34711489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19.
    D'Agnillo F; Walters KA; Xiao Y; Sheng ZM; Scherler K; Park J; Gygli S; Rosas LA; Sadtler K; Kalish H; Blatti CA; Zhu R; Gatzke L; Bushell C; Memoli MJ; O'Day SJ; Fischer TD; Hammond TC; Lee RC; Cash JC; Powers ME; O'Keefe GE; Butnor KJ; Rapkiewicz AV; Travis WD; Layne SP; Kash JC; Taubenberger JK
    Sci Transl Med; 2021 Nov; 13(620):eabj7790. PubMed ID: 34648357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Essential role for Batf3-dependent dendritic cells in regulating CD8 T-cell response during SARS-CoV-2 infection.
    Bar-On L; Dekel H; Aftalion M; Chitlaru T; Erez N
    PLoS One; 2023; 18(12):e0294176. PubMed ID: 38150441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tissue-resident memory T cells and lung immunopathology.
    Cheon IS; Son YM; Sun J
    Immunol Rev; 2023 Jul; 316(1):63-83. PubMed ID: 37014096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type 2 Immunity and Its Impact on COVID-19 Infection in the Airways.
    Pathinayake PS; Awatade NT; Wark PAB
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lung tissue-resident memory T cells: the gatekeeper to respiratory viral (re)-infection.
    Tang J; Sun J
    Curr Opin Immunol; 2023 Feb; 80():102278. PubMed ID: 36565508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue-resident immunity in the lung: a first-line defense at the environmental interface.
    Zazara DE; Belios I; Lücke J; Zhang T; Giannou AD
    Semin Immunopathol; 2022 Nov; 44(6):827-854. PubMed ID: 36305904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2.
    Wei X; Rong N; Liu J
    Front Immunol; 2022; 13():993754. PubMed ID: 36189203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary resident memory T cells in respiratory virus infection and their inspiration on therapeutic strategies.
    Zhang M; Li N; He Y; Shi T; Jie Z
    Front Immunol; 2022; 13():943331. PubMed ID: 36032142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.